title: [All sudden hearing losses are not alike. Away from infusion therapy?].
abstract: The number of patients requiring treatment for acute functional disorders of the inner ear has increased over the last decades. The diagnosis sudden loss of hearing is made when the cause of a precipitous hearing impairment cannot be determined with clinical diagnostic means. In the large majority of such cases, the pathogenesis is unclear, with vascular, viral and autoimmune processes most commonly being considered. Against this background, numerous polypragmatic therapeutic measures are employed. In general treatment of sudden loss of hearing employs a combination of several drugs with perfusion-promoting or anti-inflammatory effects. However, the efficacy of such an approach has not been established. The present article discusses a number of known ideas on the pathogenesis of this condition, together with the associated therapeutic strategies, and reports on the importance of nitrogen oxide (NO), which as recent studies appear to show, plays an important role in the physiology of the cochlea.
authors.affiliation: Klinik für Hals-, Nasen- und Ohrenkranke, Klinikum Grosshadern der LMU München.
authors.forename: M
authors.initials: M
authors.lastname: Suckfüll
authors.forename: C
authors.initials: C
authors.lastname: Wimmer
authors.forename: K
authors.initials: K
authors.lastname: Schorn
authors.forename: K
authors.initials: K
authors.lastname: Mees
mesh_terms: D000893:Anti-Inflammatory Agents / Q000008:administration & dosage* / Q000009:adverse effects; D003937:Diagnosis, Differential; D003639:Hearing Loss, Sudden / Q000209:etiology* / Q000628:therapy; D006801:Humans; D007262:Infusions, Intravenous; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000008:administration & dosage* / Q000009:adverse effects
chemical_list: D000893:Anti-Inflammatory Agents; D014665:Vasodilator Agents